Lack of survival gain for elderly women with breast cancer

Oncologist

Volumn 16, Issue 4, 2011, Pages 415-423

  Bastiaannet, Esther ^a,b   Portielje, Johanneke E A ^c   Van De Velde, Cornelis J H ^a   De Craen, Anton J M ^b   Van Der Velde, Susanne ^a   Kuppen, Peter J K ^a   Van Der Geest Geest, Lydia G M ^d   Janssen Heijnen, Maryska L G ^e   Dekkers, Olaf M ^c   Westendorp, Rudi G J ^a   Liefers, Gerrit Jan ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Gerontology and Geriatrics ^*  (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d Integraal Kankercentrum West   (Netherlands)

^e Eindhoven Cancer Registry   (Netherlands)

Author keywords

Breast cancer; Elderly; Population based; Relative survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DEATH; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SURVIVAL TIME; TREND STUDY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; RISK; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79955567722     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2010-0234     Document Type: Article

References (22)

1. Petrakis IE, Paraskakis S. Breast cancer in the elderly. Arch Gerontol Geriatr 2010;50:179-184.
2. Tejler G, Norberg B, Dufmats M et al. Survival after treatment for breast cancer in a geographically defined population. Br J Surg 2004;91:1307-1312.
3. Hughes S, Barbachano Y, Ashley S et al. Time trends in the outcome of elderly patients with breast cancer. Breast J 2008;14:158-163.
4. Quaglia A, Tavilla A, Shack L et al. The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer 2009; 45:1006-1016.
5. Muss HB, Berry DA, Cirrincione CT et al. Adjuvant chemotherapy in older women with early-stage breast cancer. NEngl J Med 2009;360:2055-2065.
6. Bouchardy C, Rapiti E, Blagojevic S et al. Older female cancer patients: Importance, causes, and consequences of undertreatment. J Clin Oncol 2007;25:1858-1869.
7. Crivellari D, Aapro M, Leonard R et al. Breast cancer in the elderly. J Clin Oncol 2007;25:1882-1890.
8. Louwman WJ, Vulto JC, Verhoeven RH et al. Clinical epidemiology of breast cancer in the elderly. Eur J Cancer 2007;43:2242-2252.
9. Louwman WJ, Janssen-Heijnen ML, Houterman S et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: A population-based study. Eur J Cancer 2005;41:779-785.
10. Mustacchi G, Milani S, Pluchinotta A et al. Tamoxifen or surgery plus tamoxifen as primary treatment for elderly patients with operable breast cancer: The G.R.E.T.A. Trial. Group for Research on Endocrine Therapy in the Elderly. Anticancer Res 1994;14:2197-2200.
11. Hind D, Wyld L, Reed MW. Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review. Br J Cancer 2007;96:1025-1029.
12. Bontenbal M, Nortier JW, Beex LV et al. [Adjuvant systemic therapy for patients with resectable breast cancer: Guideline from the Dutch National Breast Cancer Platform and the Dutch Society for Medical Oncology]. Ned Tijdschr Geneeskd 2000;144:984-989.
13. Albrand G, Terret C. Early breast cancer in the elderly: Assessment and management considerations. Drugs Aging 2008;25:35-45.
14. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 2005; 365:1687-1717.
15. Lewis JH, Kilgore ML, Goldman DP et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003;21: 1383-1389.
16. Hernandez RK, Sørensen HT, Pedersen L et al. Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism: A Danish population-based cohort study. Cancer 2009;115:4442-4449.
17. Yancik R, Havlik RJ, Wesley MN et al. Cancer and comorbidity in older patients: A descriptive profile. Ann Epidemiol 1996;6:399-412.
18. Bergman L, Dekker G, van Kerkhoff EH et al. Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer. Breast Cancer Res Treat 1991;18:189-198.
19. Houterman S, Janssen-Heijnen ML, Verheij CD et al. Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer 2004;90:2332-2337.
20. Sant M, Francisci S, Capocaccia R et al. Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer 2006; 119:2417-2422.
21. Sant M, Allemani C, Berrino F et al. Breast carcinoma survival in Europe and the United States. Cancer 2004;100:715-722.
22. Repetto L, Pietropaolo M, Aapro M. Chemotherapy in the elderly with breast cancer. Forum (Genova) 2002;12:64-70.